Baxter announcement On Oct. 31, it restarted the higher-throughput IV solutions manufacturing line at its North Cove, North Carolina, facility, which normally accounts for nearly 25% of the site’s total production and about 50% of its solutions. One liter IV – the most commonly used size. by hospitals and clinics. The first new products could start shipping in late November, Baxter said. The company continues to evaluate and repair equipment at the facility and is working with the Food and Drug Administration to resume operations in stages. Baxter said he did not have a timetable for when production at the plant would be restored to pre-Hurricane Helene levels.